Biomea Fusion (BMEA) News Today $2.18 -0.12 (-5.00%) As of 10:21 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Biomea Fusion (BMEA) to Release Earnings on MondayBiomea Fusion (NASDAQ:BMEA) will be releasing earnings before the market opens on Monday, April 7, Financial Modeling Prep reports.March 31 at 1:41 AM | marketbeat.comBrokerages Set Biomea Fusion, Inc. (NASDAQ:BMEA) PT at $24.64March 30 at 1:31 AM | americanbankingnews.comBiomea Fusion, Inc. (NASDAQ:BMEA) Given Average Rating of "Buy" by BrokeragesShares of Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) have earned an average recommendation of "Buy" from the thirteen analysts that are covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold rating, nine have given a buy rating and two have assignedMarch 27, 2025 | marketbeat.comBiomea Fusion, Inc.: Biomea Fusion Announces Leadership TransitionMarch 26, 2025 | finanznachrichten.deBiomea Fusion price target lowered to $10 from $50 at OppenheimerMarch 26, 2025 | markets.businessinsider.comBiomea Fusion appoints Mick Hitchcock to succeed Thomas Butler as interim CEOMarch 26, 2025 | msn.comBiomea Fusion names Mick Hitchcock to succeed Thomas Butler as interim CEOMarch 26, 2025 | markets.businessinsider.comHC Wainwright Reaffirms "Buy" Rating for Biomea Fusion (NASDAQ:BMEA)March 26, 2025 | americanbankingnews.comBiomea Fusion Names Hitchcock as Interim CEO, Succeeding ButlerMarch 25, 2025 | marketwatch.comBiomea Fusion Announces Leadership TransitionMarch 25, 2025 | globenewswire.comBarclays Sticks to Its Hold Rating for Biomea Fusion (BMEA)March 25, 2025 | markets.businessinsider.comHC Wainwright Reiterates Buy Rating for Biomea Fusion (NASDAQ:BMEA)HC Wainwright reissued a "buy" rating and set a $40.00 price target on shares of Biomea Fusion in a report on Monday.March 25, 2025 | marketbeat.comBiomea Fusion announces presentation of icovamenib preclinical, clinical dataMarch 25, 2025 | markets.businessinsider.comIcovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last DoseMarch 24, 2025 | globenewswire.comBiomea Fusion (BMEA) Expected to Announce Quarterly Earnings on MondayBiomea Fusion (NASDAQ:BMEA) will be releasing earnings before the market opens on Monday, March 24, Financial Modeling Prep reports.March 23, 2025 | marketbeat.comBiomea Fusion Insiders Recover Some Losses, Which Stand At US$91kMarch 22, 2025 | finance.yahoo.comD. Boral Capital Reiterates Buy Rating for Biomea Fusion (NASDAQ:BMEA)D. Boral Capital reaffirmed a "buy" rating and set a $16.00 price objective on shares of Biomea Fusion in a report on Wednesday.March 20, 2025 | marketbeat.comBiomea Fusion reports inducement grant under Nasdaq listing ruleMarch 3, 2025 | markets.businessinsider.comBiomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)March 3, 2025 | globenewswire.comBiomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of "Buy" from AnalystsBiomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) has been given an average recommendation of "Buy" by the thirteen ratings firms that are presently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and twoMarch 2, 2025 | marketbeat.comBiomea Fusion to unveil ew icovamenib data at ATTD 2025February 27, 2025 | markets.businessinsider.comBiomea Fusion to Unveil New Icovamenib Data at the 18th International Conference on Advanced Technologies & Treatments for DiabetesFebruary 27, 2025 | globenewswire.comBiomea Fusion, Inc. (NASDAQ:BMEA) Short Interest Down 12.6% in JanuaryBiomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the target of a significant decrease in short interest in January. As of January 31st, there was short interest totalling 10,730,000 shares, a decrease of 12.6% from the January 15th total of 12,280,000 shares. Approximately 33.9% of the shares of the company are sold short. Based on an average daily trading volume, of 802,000 shares, the days-to-cover ratio is currently 13.4 days.February 17, 2025 | marketbeat.comBiomea Fusion, Inc. (NASDAQ:BMEA) is a favorite amongst institutional investors who own 51%February 6, 2025 | finance.yahoo.comBiomea Fusion, Inc. (NASDAQ:BMEA) Given Consensus Recommendation of "Buy" by BrokeragesShares of Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) have been assigned a consensus recommendation of "Buy" from the thirteen brokerages that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, nine have given a buy raFebruary 5, 2025 | marketbeat.comShort Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Expands By 6.2%Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the recipient of a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 11,540,000 shares, a growth of 6.2% from the December 31st total of 10,870,000 shares. Based on an average daily volume of 891,600 shares, the days-to-cover ratio is currently 12.9 days. Approximately 36.5% of the shares of the company are short sold.February 3, 2025 | marketbeat.comBiomea Fusion’s Strategic Focus on Metabolic Diseases and Promising Pipeline Advances Garner Buy RatingJanuary 14, 2025 | markets.businessinsider.comHC Wainwright Reaffirms Buy Rating for Biomea Fusion (NASDAQ:BMEA)HC Wainwright reiterated a "buy" rating and issued a $40.00 price target on shares of Biomea Fusion in a research note on Tuesday.January 14, 2025 | marketbeat.comBiomea Fusion to become diabetes, obesity medicines companyJanuary 13, 2025 | markets.businessinsider.comBiomea Fusion price target lowered to $16 from $128 at D. Boral CapitalJanuary 13, 2025 | markets.businessinsider.comBiomea Fusion to Become a Diabetes & Obesity Medicines CompanyJanuary 13, 2025 | markets.businessinsider.comBiomea Fusion, Inc. (NASDAQ:BMEA) Receives Average Rating of "Buy" from AnalystsShares of Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) have received a consensus rating of "Buy" from the thirteen brokerages that are covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation, nine have issued a buy recommendation and twJanuary 11, 2025 | marketbeat.comBiomea Fusion's (BMEA) Buy Rating Reaffirmed at D. Boral CapitalD. Boral Capital reiterated a "buy" rating and set a $128.00 price target on shares of Biomea Fusion in a report on Friday.January 10, 2025 | marketbeat.comScotiabank Sticks to Its Buy Rating for Biomea Fusion (BMEA)January 8, 2025 | markets.businessinsider.comBiomea Fusion reports new preclinical data on icovamenib-semaglutide studyJanuary 8, 2025 | markets.businessinsider.comBiomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination StudyJanuary 7, 2025 | markets.businessinsider.comBiomea Fusion, Inc. (NASDAQ:BMEA) Sees Large Growth in Short InterestBiomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 10,870,000 shares, an increase of 9.6% from the November 30th total of 9,920,000 shares. Based on an average daily trading volume, of 953,600 shares, the short-interest ratio is currently 11.4 days. Currently, 34.4% of the company's shares are sold short.December 31, 2024 | marketbeat.comBarclays Remains a Hold on Biomea Fusion (BMEA)December 18, 2024 | markets.businessinsider.comBiomea Fusion (BMEA) Receives a Buy from Truist FinancialDecember 18, 2024 | markets.businessinsider.comBiomea Fusion, Inc.: Biomea Fusion Announces Positive Topline Results from Ongoing Phase II COVALENT-111 Study in Patients with Type 2 DiabetesDecember 18, 2024 | finanznachrichten.deWhat's Driving Biomea Fusion? Stock Soars 25%December 17, 2024 | markets.businessinsider.comBiomea Fusion's (BMEA) Buy Rating Reiterated at D. Boral CapitalD. Boral Capital restated a "buy" rating and set a $128.00 price objective on shares of Biomea Fusion in a research report on Tuesday.December 17, 2024 | marketbeat.comBiomea Fusion Announces Positive Topline Results from Ongoing Phase II COVALENT-111 Study in Patients with Type 2 DiabetesDecember 17, 2024 | globenewswire.comBiomea Fusion, Inc. (NASDAQ:BMEA) Given Consensus Rating of "Buy" by AnalystsBiomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) has earned a consensus recommendation of "Buy" from the thirteen research firms that are presently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating, nine have issued a buy rating and twoDecember 17, 2024 | marketbeat.comBiomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)December 16, 2024 | globenewswire.comBiomea Fusion, Inc. (NASDAQ:BMEA) Short Interest Up 5.4% in NovemberBiomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the recipient of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 9,920,000 shares, a growth of 5.4% from the November 15th total of 9,410,000 shares. Based on an average daily trading volume, of 773,600 shares, the short-interest ratio is currently 12.8 days. Currently, 31.4% of the company's stock are sold short.December 16, 2024 | marketbeat.comD. Boral maintains Buy rating, $128 target on Biomea Fusion after presentationsDecember 14, 2024 | markets.businessinsider.comBiomea Fusion Announces Oral and Poster Presentations of Icovamenib at the 22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)December 12, 2024 | globenewswire.comOppenheimer Keeps Their Buy Rating on Biomea Fusion (BMEA)December 11, 2024 | markets.businessinsider.comBiomea Fusion (BMEA) Gets a Hold from BarclaysDecember 11, 2024 | markets.businessinsider.com Remove Ads Get Biomea Fusion News Delivered to You Automatically Sign up to receive the latest news and ratings for BMEA and its competitors with MarketBeat's FREE daily newsletter. Email Address BMEA Media Mentions By Week BMEA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMEA News Sentiment▼0.410.82▲Average Medical News Sentiment BMEA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMEA Articles This Week▼163▲BMEA Articles Average Week Remove Ads Get Biomea Fusion News Delivered to You Automatically Sign up to receive the latest news and ratings for BMEA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ETON News MREO News RVNC News RAPP News SLDB News HRTX News ALLO News ARCT News ATXS News GLUE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMEA) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomea Fusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biomea Fusion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BMEA Stock Free BMEA Stock Alerts